Related Experiment Videos
HIV surveillance among injecting drug users
D C Des Jarlais1, K Dehne, J Casabona
1Edmond de Rothschild Foundation, Chemical Dependency Institute, Beth Israel Medical Center, 1st Avenue and 16th Street, New York, NY 10003, USA. dcdesjarla@aol.com
AIDS (London, England)
|June 26, 2001
Summary
Injecting drug users (IDUs) are a high-risk group for HIV. Surveillance should track risk behaviors and prevention program engagement to reduce infections in this partially hidden population.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Research
Background:
- Injecting drug users (IDUs) represent a partially hidden population with a high risk of HIV infection.
- Reaching and sampling IDUs is challenging due to their hidden nature, precluding traditional enumeration and random sampling methods.
Purpose of the Study:
- To emphasize the importance of including risk behaviors in surveillance studies for injecting drug users (IDUs).
- To guide the development and refinement of HIV prevention programs tailored to IDUs.
- To identify key objectives for surveillance research in this population.
Main Methods:
- Conducting surveillance research with IDUs in various settings like treatment programs, law enforcement, and street outreach.
- Including assessment of risk behaviors such as sharing injection equipment, partner change, and sexual risk behaviors.
- Collecting data on population size, drug use patterns, equipment availability, prevention participation, and antiretroviral treatment access.
Main Results:
- Surveillance focusing solely on HIV infection is not time-sensitive enough for effective prevention programming.
- Multiple settings can be utilized to establish contact with IDUs, each with unique advantages, disadvantages, and ethical considerations.
- HIV testing within surveillance raises significant ethical concerns.
Conclusions:
- Surveillance research for IDUs must integrate risk behavior assessment alongside HIV status to inform prevention strategies.
- Effective surveillance requires understanding population dynamics, drug use patterns, and access to prevention and treatment resources.
- Estimating HIV incidence often relies on indirect measurements due to the lack of cost-efficient direct methods.